financetom
Business
financetom
/
Business
/
Global aluminium producer seeks Q3 premiums of $175/T -sources
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Global aluminium producer seeks Q3 premiums of $175/T -sources
May 28, 2024 8:22 PM

TOKYO, May 29 (Reuters) - A global aluminium producer

has offered Japanese buyers a premium of $175 per metric ton for

July-September primary metal shipments, up 18% to 21% from the

current quarter, three sources directly involved in quarterly

pricing talks said on Wednesday.

Japan is major Asian importer of the light metal and the

premiums for primary metal shipments it agrees to pay each

quarter over the London Metal Exchange (LME) cash price

set the benchmark for the region.

For the April-June quarter, Japanese buyers agreed to pay a

premium of $145-$148 per ton , up 61% to 64% from

the prior quarter.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copper output from Chile's Codelco down 6% in April
Copper output from Chile's Codelco down 6% in April
Jun 7, 2024
SANTIAGO, June 7 (Reuters) - Copper production from Chile's state-run miner Codelco, the world's largest producer of the metal, dropped 6.1% in April compared to the same month last year to total 95,100 metric tons, data from copper commission Cochilco showed on Friday. Copper output also fell during the month at Chile's Escondida mine, though it edged up 1.9% in...
Chemed Insider Sold Shares Worth $816,255, According to a Recent SEC Filing
Chemed Insider Sold Shares Worth $816,255, According to a Recent SEC Filing
Jun 7, 2024
03:16 PM EDT, 06/07/2024 (MT Newswires) -- Kevin J McNamara, Director, President and CEO, on June 06, 2024, sold 1,500 shares in Chemed ( CHE ) for $816,255. Following the Form 4 filing with the SEC, McNamara has control over a total of 107,049 shares of the company, with 107,049 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/19584/000095017024070509/xslF345X03/ownership.xml Price: 544.96, Change: +0.79,...
Arcturus Therapeutics Prospective Cystic Fibrosis Treatment Shows Positive Results -- Shares Tumble
Arcturus Therapeutics Prospective Cystic Fibrosis Treatment Shows Positive Results -- Shares Tumble
Jun 7, 2024
03:16 PM EDT, 06/07/2024 (MT Newswires) -- Arcturus Therapeutics ( ARCT ) slumped more than 29% in Friday trading, despite reporting positive preliminary data from phase 1 and phase 1b study of its ARCT-032 prospective treatment for cystic fibrosis. Appearing at an industry conference in Glasgow, Scotland, executives of the the messenger RNA medicines and vaccines company said the inhaled...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
Jun 7, 2024
(Reuters) - A 15-day course of Pfizer's ( PFE ) COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according a study by Stanford University researchers. Currently, there are no proven treatments specifically for long COVID in which a host of symptoms can last for many months after initial coronavirus infection. Scientists and patients had hoped that Pfizer's...
Copyright 2023-2025 - www.financetom.com All Rights Reserved